Centiva Capital’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70K Buy
28,690
+13,690
+91% +$51.7K ﹤0.01% 1577
2026
Q1
$54.9K Sell
15,000
-10,923
-42% -$41.4K ﹤0.01% 1480
2025
Q4
$76.5K Buy
25,923
+10,923
+73% +$29.9K ﹤0.01% 1104
2025
Q3
$36.3K Hold
15,000
﹤0.01% 958
2025
Q2
$49.2K Sell
15,000
-34,889
-70% -$126K ﹤0.01% 1429
2025
Q1
$192K Buy
49,889
+34,889
+233% +$145K 0.01% 1307
2024
Q4
$57.9K Sell
15,000
-40,927
-73% -$226K ﹤0.01% 1534
2024
Q3
$411K Sell
55,927
-150,800
-73% -$989K 0.01% 1385
2024
Q2
$1.33M Buy
206,727
+190,727
+1,192% +$1.52M 0.02% 628
2024
Q1
$168K Buy
16,000
+1,000
+7% +$8.16K ﹤0.01% 1515
2023
Q4
$132K Sell
15,000
-19,197
-56% -$147K ﹤0.01% 1530
2023
Q3
$281K Sell
34,197
-6,700
-16% -$64.8K 0.01% 1211
2023
Q2
$476K Buy
+40,897
New +$387K 0.01% 852

Other funds holding BAK

Centiva Capital's BAK Position: Q2 2026 in Review

Centiva Capital increased its Braskem (BAK) stake by 91% in Q2 2026, buying an estimated $51.7K and bringing the position to 28,690 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Centiva Capital first reported a position in BAK in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.33M in Q2 2024. 63 funds tracked by Wall St. Rank hold BAK as of Q2 2026.

  • Centiva Capital held 28,690 shares of Braskem worth $70K as of Q2 2026.
  • Centiva Capital bought 13,690 Braskem shares in Q2 2026, an estimated $51.7K.
  • Braskem made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1577 holding.
  • Centiva Capital first reported a position in Braskem in Q2 2023 and has held it in 13 quarters since.
  • Centiva Capital's Braskem position peaked at $1.33M in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Braskem as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.